ASHLEY CASTLE: Open Payments
NPI 1083993760 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 115 payments from 22 companies in 2025. Trend: 2023 $2,062 · 2024 $1,871 · 2025 $2,128
Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $297 |
| PFIZER INC. | 11 | $217 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| Lilly USA, LLC | 9 | $161 |
| Novo Nordisk Inc | 10 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $154 |
| Astellas Pharma US Inc | 6 | $152 |
| Dynavax Technologies Corporation | 5 | $127 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
Products named: REXULTI, VRAYLAR, XIFAXAN, Veozah, Heplisav-B, MOUNJARO, VOQUEZNA, CAPLYTA.
Industry payments across TN — which companies pay providers there.
